A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.

United States118th CongressSRES-510Senate
Updated: Dec 14, 2023

Summary

This resolution expresses the sense of the Senate that (1) policies governing access to medication abortion care should be based on scientific review by the Food and Drug Administration (FDA), and (2) the FDA has found mifepristone to be safe and effective for women seeking abortions.

Bill texts

Available versions
Introduced (Senate)View official text

1 version available

All available records shown.

Timeline

  1. Introduced in Senate

  2. Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S6003-6004)

    Senate

All available records shown.